(Q44785223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Impact of different standardized uptake value measures on PET-based quantification of treatment response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

3

Robert Jeraj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Matt Vanderhoek

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Scott B Perlman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

17 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Nuclear Medicine

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1188-1194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

[18F]FLT-PET in oncology: current status and opportunities

3 March 2020

cites work

1 reference

12 December 2020

Early changes in [18F]FLT uptake after chemotherapy: an experimental study

1 reference

12 December 2020

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

1 reference

12 December 2020

Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas

1 reference

12 December 2020

Impact of the definition of peak standardized uptake value on quantification of treatment response

1 reference

12 December 2020

A new precursor for the radiosynthesis of [18F]FLT.

1 reference

12 December 2020

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma

1 reference

12 December 2020

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

12 December 2020

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

12 December 2020

Standards for PET image acquisition and quantitative data analysis

1 reference

12 December 2020

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

1 reference

12 December 2020

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

1 reference

12 December 2020

Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

1 reference

12 December 2020

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors

1 reference

12 December 2020

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

1 reference

12 December 2020

Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters.

1 reference

12 December 2020

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

1 reference

12 December 2020

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

1 reference

12 December 2020

Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography.

1 reference

12 December 2020

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

1 reference

12 December 2020

Activity of sunitinib in patients with advanced neuroendocrine tumors

1 reference

12 December 2020

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

12 December 2020

18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study

1 reference

12 December 2020

Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography

1 reference

12 December 2020

Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose.

1 reference

12 December 2020

Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography

1 reference

12 December 2020

Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

1 reference

12 December 2020

Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors

1 reference

12 December 2020

[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung

1 reference

12 December 2020

Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer

1 reference

12 December 2020

The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

1 reference

12 December 2020

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

12 December 2020

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.

1 reference

12 December 2020

Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma

1 reference

12 December 2020

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer

1 reference

12 December 2020

Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET

1 reference

12 December 2020

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

1 reference

12 December 2020

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

1 reference

12 December 2020

10.2967/JNUMED.112.113332

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

23776199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23776199%20AND%20SRC:MED&resulttype=core&format=json